Skip to main content
Premium Trial:

Request an Annual Quote

JMP Genomics 3.2, OneTouch Pipette Tips

Premium
SAS has launched JMP Genomics 3.2, which streamlines analysis workflows for expression, exon, copy number, and genotype data. Among other changes, the product has a simplified user interface and includes new support for importing copy number CHP files from the Affymetrix Genotyping Console software and for importing expression data from Illumina BeadStudio software, the company said.
 

 
Sorenson BioScience has launched OneTouch pipette tips and e.dek pipette tip rack. The top of the ergonomically designed pipette tips is made of a flexible resin that produces a seal while requiring minimal force to eject the tip. The pliable top fits a wide range of pipettors, including multi-channel pipettors and pipettors with worn shafts. The second resin is a non-reactive polypropylene traditionally used in pipette tips.
 

Currently, 200 µl tips are available. 20µl and 1,000 µl tips are scheduled to ship in the third quarter.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.